#FutureOfSABR Twitter Takeover
Do you have unanswered questions on the #FutureOfSABR?
Join Dr James Good, Clinical Director of Stereotactic Radiotherapy LIVE on GenesisCare Twitter Thursday 10th June from 6pm BST in a conversation on ‘Emerging Indications in Stereotactic Ablative Radiotherapy & MR-guided radiotherapy.’
An extremely hypofractionated treatment delivered in just 1 to 5 fractions, this revolutionary evidence-based alternative to surgery is highly effective in the management of primary and metastatic tumours and is available across the GenesisCare network.
We look forward to engaging with the SABR community.
For more information on SABR, contact SABR@genesiscare.co.uk
Dr James Good
Clinical Director of Streotactic Radiotherapy
As our Clinical Director of SABR and MR-guided radiotherapy, James focuses on cutting edge, personalised treatment of cancers of the head & neck, bowel and rectum using chemotherapy, radiotherapy, targeted therapy, and immunotherapy. View details
Stereotactic Ablative Radiotherapy (SABR)
A centre for excellence of SABR
Also known as Stereotactic Body Radiation Therapy (SBRT), SABR is acknowledged as one of the most advanced radiotherapy techniques providing a non-invasive cancer treatment option for patients with tumours such as in the lung and liver. This cutting-edge therapy targets tumours with the aim to destroy cancer cells with minimal damage to the surrounding healthy tissue.
As a centre of excellence for SABR, we are proud to offer this world-class service to patients led by a team of leading SABR specialists. The service aims to deliver clinical excellence at each stage of the patient pathway.
Read more on SABR here
MRIdian MR-guided radiotherapy
A new frontier for SABR delivery, we are proud to be the first private cancer care provider in the UK to introduce the MRIdian MR-guided radiotherapy.
By combining linear accelerator with a high-definition MR scanner, the MRIdian enables clinicians to see as they treat, bringing a new level of control and confidence to targeting tumours and sparing damage to healthy tissue. Treatment on the MRIdian is available to patients from throughout the UK at our centres in Oxford and at Cromwell Hospital in London.
Read more on MR-guided radiotherapy here